Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-07-13
DOI
10.1038/s41598-017-05859-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Autophagy in 5-Fluorouracil Therapy in Gastrointestinal Cancer: Trends and Challenges
- (2016) Xiu-Jun Cai et al. CHINESE MEDICAL JOURNAL
- EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer Model
- (2015) Tao Wang et al. Theranostics
- Ionizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: possible involvement in radioresistance
- (2014) P Dahan et al. Cell Death & Disease
- Aptamers: Molecules of great potential
- (2013) Filip Radom et al. BIOTECHNOLOGY ADVANCES
- Cancer stem cells: A contentious hypothesis now moving forward
- (2013) Michael L. O’Connor et al. CANCER LETTERS
- S6K1 inhibition enhances tamoxifen-induced cell death in MCF-7 cells through translational inhibition of Mcl-1 and survivin
- (2013) Sung-Eun Hong et al. CELL BIOLOGY AND TOXICOLOGY
- Site-specific antibody drug conjugates for cancer therapy
- (2013) Siler Panowski et al. mAbs
- EpCAM overexpression prolongs proliferative capacity of primary human breast epithelial cells and supports hyperplastic growth
- (2013) Agnieszka Martowicz et al. Molecular Cancer
- Resistance of colon cancer to 5-fluorouracil may be overcome by combination with chloroquine, an in vivo study
- (2012) Kazuhito Sasaki et al. ANTI-CANCER DRUGS
- RNA aptamers targeting cancer stem cell marker CD133
- (2012) Sarah Shigdar et al. CANCER LETTERS
- Targeting survivin in cancer
- (2012) Dario C. Altieri CANCER LETTERS
- Impairment of Glioma Stem Cell Survival and Growth by a Novel Inhibitor for Survivin-Ran Protein Complex
- (2012) H. Guvenc et al. CLINICAL CANCER RESEARCH
- A Detailed Mammosphere Assay Protocol for the Quantification of Breast Stem Cell Activity
- (2012) Frances L. Shaw et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma
- (2011) Bruce D. Cheson et al. CANCER
- ABCB5 Identifies a Therapy-Refractory Tumor Cell Population in Colorectal Cancer Patients
- (2011) B. J. Wilson et al. CANCER RESEARCH
- RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule
- (2011) Sarah Shigdar et al. CANCER SCIENCE
- Cancer Stem Cells and Chemosensitivity
- (2011) M. Maugeri-Sacca et al. CLINICAL CANCER RESEARCH
- Apoptosis gene signature of Survivin and its splice variant expression in breast carcinoma
- (2011) Frédérique Végran et al. ENDOCRINE-RELATED CANCER
- Induction of Apoptosis by Survivin Silencing through siRNA Delivery in a Human Breast Cancer Cell Line
- (2011) Hamidreza Montazeri Aliabadi et al. MOLECULAR PHARMACEUTICS
- Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state
- (2011) C. L. Chaffer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Survivin and IAP proteins in cell-death mechanisms
- (2010) Dario C. Altieri BIOCHEMICAL JOURNAL
- Expression of survivin detected by immunohistochemistry in the cytoplasm and in the nucleus is associated with prognosis of leiomyosarcoma and synovial sarcoma patients
- (2010) Helge Taubert et al. BMC CANCER
- Inhibition of autophagy augments 5-fluorouracil chemotherapy in human colon cancer in vitro and in vivo model
- (2010) Jie Li et al. EUROPEAN JOURNAL OF CANCER
- The immunogenicity of humanized and fully human antibodies
- (2010) Fiona A. Harding et al. mAbs
- Epithelial cell adhesion molecule (EpCAM) is overexpressed in breast cancer metastases
- (2009) Ashley Cimino et al. BREAST CANCER RESEARCH AND TREATMENT
- Chemoresistant Colorectal Cancer Cells, the Cancer Stem Cell Phenotype, and Increased Sensitivity to Insulin-like Growth Factor-I Receptor Inhibition
- (2009) N. A. Dallas et al. CANCER RESEARCH
- Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution
- (2009) Mark Shackleton et al. CELL
- Phase I Study of YM155, a Novel Survivin Suppressant, in Patients with Advanced Solid Tumors
- (2009) T. Satoh et al. CLINICAL CANCER RESEARCH
- A multi-center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage III or IV melanoma
- (2009) Karl D. Lewis et al. INVESTIGATIONAL NEW DRUGS
- Multicenter Phase II Trial of YM155, a Small-Molecule Suppressor of Survivin, in Patients With Advanced, Refractory, Non–Small-Cell Lung Cancer
- (2009) Giuseppe Giaccone et al. JOURNAL OF CLINICAL ONCOLOGY
- Association of reactive oxygen species levels and radioresistance in cancer stem cells
- (2009) Maximilian Diehn et al. NATURE
- Regulation of Mammary Stem/Progenitor Cells by PTEN/Akt/β-Catenin Signaling
- (2009) Hasan Korkaya et al. PLOS BIOLOGY
- Survival of the Fittest: Cancer Stem Cells in Therapeutic Resistance and Angiogenesis
- (2008) Christine E. Eyler et al. JOURNAL OF CLINICAL ONCOLOGY
- Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy
- (2008) Scott J. Dylla et al. PLoS One
- Colon cancer stem cells: implications for prevention and therapy
- (2008) Emina H. Huang et al. TRENDS IN MOLECULAR MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More